Cerus (CERS) Share-based Compensation (2010 - 2026)
Cerus' (CERS) quarterly Share-based Compensation came in at $4.9 million in Q1 2026, down 26.09% year-on-year from $6.6 million in Q1 2025, and little changed quarter-over-quarter from $4.9 million in Q4 2025.
Cerus (CERS) Share-based Compensation (2010 - 2026) Analysis & Trends
Cerus has disclosed Share-based Compensation across 17 years of filings, most recently posting $4.9 million for Q1 2026.
- Share-based Compensation for Q1 2026 came in at $4.9 million, down 26.09% year-over-year; the trailing twelve-month figure through Mar 2026 was $21.1 million (down 10.62% YoY), and the FY2025 annual result was $22.9 million, changed 0.0% from the prior year.
- Share-based Compensation came in at $4.9 million for Q1 2026 at Cerus, roughly flat from $4.9 million in the prior quarter.
- In the past five years, Share-based Compensation ranged from a high of $7.3 million in Q4 2022 to a low of $4.0 million in Q3 2023.
- The 5-year median for Share-based Compensation is $5.7 million (2024), against an average of $5.6 million.
- Across the five-year window, Share-based Compensation plunged 32.42% in 2023 and soared 46.52% in 2024, its largest moves.
- Cerus' Share-based Compensation stood at $7.3 million in 2022, then slumped by 32.42% to $4.9 million in 2023, then increased by 12.26% to $5.5 million in 2024, then decreased by 10.48% to $4.9 million in 2025, then slipped by 0.47% to $4.9 million in 2026.
- The last three Share-based Compensation figures came in at $4.9 million (Q1 2026), $4.9 million (Q4 2025), and $5.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | 317.00 Mn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 87.00 Mn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | 94.00 Mn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 83.00 Mn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | 45.40 Mn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 35.00 Mn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 35.12 Mn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 43.30 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 12.90 Mn |
| 10 | Cerus | 496.03 Mn | 416.34 Mn | 27.89 Mn | 4.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.90 Mn |
| Mar 31, 2026 | 4.90 Mn |
| Dec 31, 2025 | 4.93 Mn |
| Dec 31, 2025 | 4.93 Mn |
| Sep 30, 2025 | 5.62 Mn |
| Sep 30, 2025 | 5.62 Mn |
| Jun 30, 2025 | 5.68 Mn |
| Jun 30, 2025 | 5.68 Mn |
| Mar 31, 2025 | 6.64 Mn |
| Mar 31, 2025 | 6.64 Mn |
| Dec 31, 2024 | 5.50 Mn |
| Dec 31, 2024 | 5.50 Mn |
| Sep 30, 2024 | 5.83 Mn |
| Sep 30, 2024 | 5.83 Mn |
| Jun 30, 2024 | 5.68 Mn |
| Jun 30, 2024 | 5.68 Mn |
| Mar 31, 2024 | 5.86 Mn |
| Mar 31, 2024 | 5.86 Mn |
| Dec 31, 2023 | 4.90 Mn |
| Dec 31, 2023 | 4.90 Mn |